Evaro

Evaro is a digital healthcare platform transforming how patients access everyday medical services. Through its direct-to-consumer offering, users can seamlessly consult with licensed clinicians, receive prescriptions, and get medications delivered—all from the convenience of their devices. Designed for speed, safety, and accessibility, Evaro makes managing minor health issues simple and stress-free.

Evaro also operates a B2B2C model, enabling businesses to integrate white-labelled clinical services into their own customer journeys. With a plug-and-play solution, brands can offer healthcare consultations, prescription issuance, and aftercare under their own name—without the regulatory or operational burden. This dual approach allows Evaro to meet patients where they are, while helping partners unlock new value and deliver essential healthcare services at scale.

We believe Evaro is addressing a critical pain point in the healthcare system: the need for fast, affordable, and accessible medical support. Spearheaded by mission-driven founders, the company has built a highly scalable, AI-powered platform that reimagines how patients access care—offering a seamless experience from consultation to prescription. Evaro has demonstrated strong market demand and user engagement, underpinned by repeat usage and organic growth. With a defensible regulatory position, strong early partnerships, and a capital-efficient model, we believe Evaro is well-positioned to lead the evolution of digital healthcare delivery.